Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma.

MLA

Delioukina, Maria L., et al. “Phase II Trial of Irinotecan in Combination with Amifostine in Patients with Advanced Colorectal Carcinoma.” Cancer, vol. 94, no. 8, Apr. 2002, pp. 2174–79. EBSCOhost, https://doi.org/10.1002/cncr.10432.

APA

Delioukina, M. L., Prager, D., Parson, M., Hecht, J. R., Rosen, P., & Rosen, L. S. (2002). Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma. Cancer, 94(8), 2174–2179. https://doi.org/10.1002/cncr.10432

Chicago

Delioukina, Maria L, Diane Prager, Mandy Parson, J Randolph Hecht, Peter Rosen, and Lee S Rosen. 2002. “Phase II Trial of Irinotecan in Combination with Amifostine in Patients with Advanced Colorectal Carcinoma.” Cancer 94 (8): 2174–79. doi:10.1002/cncr.10432.